If you need more lookups,
subscriptions start at $34 USD/month.
Jingru Wang Location
Shanghai, China
Jingru Wang Work
Associate Vice President, Clinical Development @ (October 2024 - Present)
Senior Director Clinical Development @ (October 2022 - Present)
Director Clinical Development @ (October 2020 - October 2022)
Associate Director Clinical Science @ (October 2019 - September 2020)
Principal clinical scientist @ (December 2017 - September 2019)
Scientist III @ (March 2015 - November 2017)
Scientist II @ (March 2013 - February 2015)
Scientist I @ (May 2012 - February 2013)
Senior Research Assistant @ (May 2009 - April 2012)
Jingru Wang Education
Shanghai institue of materia medica, CAS
Doctor of Philosophy - PhD (neuropharmacology)
2005-2009
Shenyang Pharmaceutical University
硕士 (微生物与生化药学)
2002-2004
Jilin University
学士 (生物技术制药)
1998-2002
Jingru Wang Skills
Pharmaceutical Industry
Biotechnology
Drug Discovery
Have rich experience in setting up high throughput screening methods
Molecular biology, cellular biology and biochemistry study
Plan and organize in vivo study to evaluate molecule's PK/PD
Evaluate and validate new target
药品研发
高通量筛选
分子生物学
生物化学
细胞培养
In vivo
制药业
生物技术
临床研究
药品开发
生命科学
临床试验
Clinical Development
Data Science
Good Clinical Practice (GCP)
Medical Research
Oncology
Pharmacology
Research and Development (R&D)
Jingru Wang Summary
Jingru Wang, based in Shanghai, China, is currently a Associate Vice President, Clinical Development at CStone Pharmaceuticals. Jingru Wang brings experience from previous roles at CStone Pharmaceuticals. Jingru Wang holds a 2005 - 2009 Doctor of Philosophy - PhD in neuropharmacology @ Shanghai institue of materia medica, CAS. With a robust skill set that includes Pharmaceutical Industry, Biotechnology, Drug Discovery, Have rich experience in setting up high throughput screening methods, Molecular biology, cellular biology and biochemistry study and more. Jingru Wang has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Jingru Wang?
Find contact details for 700 million professionals.